Clarus Therapeutics Holdings, Inc. - Common Stock (NQ:CRXT)
Price and Volume
Detailed Quote| Volume | 0 | 
| Open | - | 
| Bid (Size) | 0.1000 (70) | 
| Ask (Size) | 0.1010 (2) | 
| Prev. Close | 0.0990 | 
| Today's Range | N/A - N/A | 
| 52wk Range | N/A - N/A | 
| Shares Outstanding | 52,020,731 | 
| Dividend Yield | N/A | 
Top News
More NewsPerformance
More News
Read More
    Testosterone-Drug Focused Penny Stock Falls On Bankruptcy Fears
    
   
  August 19, 2022
   
    Here's Why Clarus Therapeutics Shares Got Obliterated
    
   
  August 29, 2022
   
    Why Is Pinduoduo (PDD) Stock Up 18% Today?
    
   
  August 29, 2022
   
    Dear AMC Stock Fans, Mark Your Calendars for Sept. 3
    
   
  August 29, 2022
   
    Why Is Humanigen (HGEN) Stock Down 16% Today?
    
   
  August 29, 2022
   
    Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2022
    
   
  August 23, 2022
   
    Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2022
    
   
  August 22, 2022
   
    Wayfair, Bed Bath & Beyond And Other Big Losers From Friday
    
   
  August 22, 2022
   
    Stocks That Hit 52-Week Lows On Monday
    
   
  July 25, 2022
   Frequently Asked Questions
Is Clarus Therapeutics Holdings, Inc. - Common Stock publicly traded?
   Yes, Clarus Therapeutics Holdings, Inc. - Common Stock is publicly traded.
  What exchange does Clarus Therapeutics Holdings, Inc. - Common Stock trade on?
   Clarus Therapeutics Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
  What is the ticker symbol for Clarus Therapeutics Holdings, Inc. - Common Stock?
   The ticker symbol for Clarus Therapeutics Holdings, Inc. - Common Stock is CRXT on the Nasdaq Stock Market
  
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
   